#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Breast cancer metastatic Hepatocellular carcinoma Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Type 2 diabetes mellitus Chronic lymphocytic leukaemia More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Non-renal cell carcinoma of kidney B-cell lymphoma refractory Gastric cancer Transitional cell cancer of the renal pelvis and ureter CDKL5 deficiency disorder Haemophilia A with anti factor VIII Indolent systemic mastocytosis Fungal infection Pyoderma gangrenosum Hereditary angioedema Cutaneous T-cell lymphoma Drug eruption Hyperchylomicronaemia Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Atypical haemolytic uraemic syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Richter’s syndrome – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Mucous membrane pemphigoid – Trials in Disease Krabbe’s disease – Life with Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Mbf-118 Lidocaine Vortioxetine Chlorphenamine Maleate Pantoprazole Amoxicillin Sodium Bempedoic Acid Topiramate Iomeprol Thiotepa Vilobelimab Salbutamol Psma-11 Metolazone Azilsartan Medoxomil Tobramycin Bictegravir Valganciclovir Hydrochloride Pristinamycin More therapies…

    Learn about Your Condition

    Myocarditis Meniere's disease Factor VIII deficiency Osteomyelitis Pulmonary fibrosis Bronchostenosis Tooth loss Alport's syndrome Lymphangioma Pulmonary tuberculosis Medication overuse headache Haematological infection Seizure Round cell liposarcoma Cerebellar ataxia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lithuania

  • Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    1 1 1
    Investigated drugs:
    • Nemolizumab
    Austria Belgium Bulgaria Czechia Estonia France +8
  • Study on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Aztreonam
    • Cefepime
    • Cilastatin Sodium
    Bulgaria Czechia Estonia Latvia Lithuania Slovakia
  • Study of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    1 1 1
    Investigated drugs:
    • Aflibercept
    • Vascular Endothelial Growth Factor Receptor 3 Extracellular Domains 1-3 Fused To A Igg1 Fc Fragment
    Austria Bulgaria Croatia Czechia Estonia France +10
  • Study of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Oesophageal cancer metastatic
    • Oesophageal carcinoma
    • Gastric cancer
    Investigated drugs:
    • Calcium Folinate
    • Capecitabine
    • Domvanalimab
    France Greece Hungary Italy Lithuania Poland +3
  • Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Peritoneal cancer index
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated drugs:
    • Nemvaleukin Alfa
    • Topotecan Hydrochloride
    • Doxorubicin Hydrochloride
    Austria Belgium Czechia Denmark France Germany +4
  • Study on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Malignant melanoma stage II
    • Malignant melanoma stage III
    Investigated drugs:
    • Pemetrexed Disodium Hemipentahydrate
    • Pembrolizumab
    Lithuania Romania Spain
Previous Page
1 … 21 22 23 24 25 … 38
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Methotrexate Cisplatin Dexamethasone Cytarabine Hydrocortisone Risankizumab Etoposide Efgartigimod Alfa Apixaban Prednisolone Oxaliplatin Prednisone Upadacitinib Paclitaxel Lenalidomide Carboplatin Sodium Chloride Olaparib Venetoclax Fluorouracil Barzolvolimab Enoxaparin Sodium Pemetrexed Azacitidine Adalimumab Duvakitug Aztreonam Capecitabine Milvexian Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired antithrombin III deficiency Acromegaly Acute coronary syndrome Acute graft versus host disease Acute leukaemia Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Acute respiratory distress syndrome Adenocarcinoma gastric Adrenogenital syndrome Alport's syndrome Anaemia Antibiotic therapy Arteriosclerosis Asthma Atrial fibrillation Axial spondyloarthritis B-cell lymphoma recurrent B-cell lymphoma refractory B-cell type acute leukaemia Bladder cancer Bronchiectasis Cardiac amyloidosis Cardiac failure Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic lymphocytic leukaemia Chronic obstructive pulmonary disease Chronic spontaneous urticaria Coagulation factor X level Cold urticaria Colitis ulcerative Colorectal cancer stage IV Conjunctivitis allergic Contraception COVID-19 Critical illness Crohn's disease Cystic fibrosis Dermatitis atopic Diabetic foot infection Dry eye Dyslipidaemia EGFR gene mutation Embolism Embolism venous Endometrial cancer Endometrial cancer metastatic Endometrial cancer recurrent Erosive oesophagitis Erythema migrans Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Gastric cancer Glioblastoma multiforme Glomerulonephritis Gout Haemophilia A with anti factor VIII Haemophilia A without inhibitors Haemophilia B without inhibitors Heparin resistance Hidradenitis Hormone-refractory prostate cancer Hyperchylomicronaemia Hypertension Hypertriglyceridaemia Idiopathic inflammatory myopathy IgA nephropathy Immune thrombocytopenia Infection prophylaxis Influenza Iron deficiency Iron deficiency anaemia Ischaemic stroke Juvenile idiopathic arthritis Lupus nephritis Macular oedema Major depression Malignant melanoma stage II Malignant melanoma stage III Metastatic gastric cancer Metastatic malignant melanoma Microsatellite instability cancer Migraine Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myelodysplastic syndrome Myelodysplastic syndrome with excess blasts Myelofibrosis Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephrogenic anaemia Nephropathy Neuroblastoma Neurogenic bladder Non-small cell lung cancer Non-small cell lung cancer metastatic Noonan syndrome Oesophageal adenocarcinoma Oesophageal cancer metastatic Oesophageal carcinoma Ovarian cancer Paroxysmal nocturnal haemoglobinuria Partial seizures Peritoneal cancer index Plasma cell myeloma Pneumonia Primary biliary cholangitis Primary myelofibrosis Progressive relapsing multiple sclerosis Prostate cancer Prostate cancer metastatic Proteinuria Psoriatic arthropathy Pulmonary arterial hypertension Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Retinal vein occlusion Rheumatoid arthritis Rhinitis allergic Schizophrenia Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Skin bacterial infection Small cell lung cancer Small cell lung cancer limited stage Small for dates baby Squamous cell carcinoma of head and neck Status epilepticus Still's disease Systemic lupus erythematosus Systemic scleroderma Thrombosis prophylaxis Transient ischaemic attack Turner's syndrome Type 2 diabetes mellitus Urinary tract infection Varicella

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!